%PDF-1.6
%
1 0 obj
<>stream
2020-06-25T12:45+05:30
2020-06-29T00:41:13-07:00
2020-06-29T00:41:13-07:00
LaTeX with hyperref package
Acrobat Distiller 10.1.16 (Windows); modified using iText 4.2.0 by 1T3XT
10.1002/cac2.12068
10.1002/(ISSN)2523-3548
3
VoR
10.1002/cac2.12068
application/pdf
A phase I study of toripalimab, an anti‐PD‐1 antibody, in patients with refractory malignant solid tumors
uuid:347666a6-2b32-308f-90ca-08373653ba48
uuid:89cace86-e4b7-4ec6-8a40-f658cf9e8297
endstream
endobj
4 0 obj
<>stream
x\[㶱~_1/F\J2:Uzķ㝜T*0eP3'h$c 6ލ͇zn+u7/nۧ7_ku}{w4uAGsS\yKW~*
3ퟮbiOSʭ5ץnWE
{++DyWW/2̇e l^5 俾z6׆^ΊIN2us7{
IUK=̦?ҹ
!SMn2~ٯͷ_K*/}y=73?'||i\`2%ͻږY4#M^]r&."V'hjLlW\)CsR0lXnb?L.J;Y*07Ro*Ǝ%pT^МjW*6Wr Usu_h7n
uye#qtIVLoy9iJiAYPԘfF&ZO1p5ڞ$.0$05O:@eul Dij3uJieΝu䯽E*LBdLTGZjVF$\3Oi`Z`s4D1Є TѨШjh20ҷ#M5j]k"@)]b*WW@\hFF͈D mIl5!6-ڕuHQT'`IVFQHt4]ٴgeIOE5a}Ј6?,61lZ@ԝQ.
&75d?c5ը+E/J]JC4i>8̦t^K0]r|k@kcs6/| VYKbJOKcP sO:J5LmRD$3u)MM^g45J5j2dsRfM8"@4̝#,)` (Hv5V2Su^h/MC4VjNPB*
n!,mZΪfR[':.bj!'{vbibG?BwR& )VWwW}җ E%|),vsuYȴhRןڧg\A=#&UX8@vN;eg UddT붛Jܯ9"Z(R$Vb)њq5]iZW3C̓mf Rgۻ8CYpSH垄 m+` f팈_g
:{%}a75kd@#e*pH?g?ę>d߂k_+hv.v?{ڿfL_"%%ǐ,4O`8،)eZ~\@krI*SdL0ST0^d
$w <9f$iEbʚv>ƿ]/ꢒ= |YGoY"&/h-Ip0)Qx ɳ2BEl)~`"Q<Ӫ-OqDĤ$Hj6ze_,b&"uU&Fyf~۷!`"ZD':E[R_n?Kzo }:ZVJ̲1Zv ל](*b~PEu~/S8@S&jq;
Nj
4x4ECpyyJxn>A:p{ 0
X9b~}n
@O$,Qת,2>UgBAlh6pGh>)xRu Gu6ԷOЀ:ky1%Y: U=rvd3,};_unA|M;'k(& ;$桵Zdȫ)ɏ%y|^֮2lo/8f'S>[MwHpNBg
>(bt߄r}6)%RpϾ϶ui26Q[~j@ݯb\]R]w3buGk'<3CK[\qADePVGXX`Kl@Scc $1p"_R,ѶO=msIq~G<&!7qwaJ/!v0ƐЖ<.8?ktP4Lo;`$]!k!u}X``!{Epm61-D3~r.D lٴQփIl4@BN\,WFǦeM"H)#hC DNj&JĶ,e~ݮVLcoD
CL <<13?%R|/1|w2BAtG;Ҝr
Gy?똦RIauQv[x0u .ͮ'O%[ozNj^aYXj8ℋڅ]CfUWò]FwGv}`e퉫YM߁<3cⳑɢf}E4Ģϴ.s\6oWnH6>jcwG#7Obz\m؇H"Tw\Ep!3[Rp-bKmyںJ羈<ŲM~>ncǣh&} 16ͬ8ނMdɳ8oXA |#
xL+SSƣD uYOnA5{u ˘xXv2ZX%j9/sޑf
Z/dw][=n,X
beXFViD,QQcڪb (40"GiG'q1HJ@Bo&_ٻ?߄?̾w_N;Mu 73 9a}]]bny]z˄OCnEd[ֲUX7*^jۗ9:"n)mcv"D,.dșZ-햭weZ;^X±)^9C|U9_p2'lmj$m#Je6mpZ(udzIg[xW.ȼ46eCURL;D F&ȔtH^4p1 i2~
RՊ|iTi@AOڱYW圫ד*~4}Z*bn=Z<